Company Filing History:
1 out of 1,309 
1 out of 676 
1 out of 1 Years Active: 2002-2020
Title: The Innovations of Gerard John Graham
Introduction
Gerard John Graham is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules and chemokine variants. With a total of four patents to his name, Graham's work has the potential to impact various medical treatments.
Latest Patents
Graham's latest patents include the development of anti-CXCL12 antibody molecules and their uses. These antibody molecules are designed to inhibit the biological activity of CXCL12 both in vitro and in vivo, offering potential treatments for CXCL12-mediated diseases. Another significant patent involves chemokine β-7 variants, which relates to deletion and substitution mutant polypeptides of human chemokine β-7. This invention also encompasses nucleic acid molecules encoding such polypeptides and processes for their production using recombinant techniques. The Ckβ-7 polypeptides described in this patent may be utilized in treating conditions such as rheumatoid arthritis, inflammation, respiratory diseases, allergies, and IgE-mediated allergic reactions.
Career Highlights
Throughout his career, Graham has worked with prominent companies in the biotechnology sector, including Wyeth and Human Genome Sciences, Inc. His experience in these organizations has contributed to his expertise and innovation in the field.
Collaborations
Graham has collaborated with notable colleagues such as Theodora W Salcedo and Vikram P Patel. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Gerard John Graham's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.